DaVita Inc. (DVA)

Market Cap	10.72B
Revenue (ttm)	12.97B
Net Income (ttm)	859.61M
Shares Out	75.50M
EPS (ttm)	10.11
PE Ratio	14.04
Forward PE	12.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	n/a
Previous Close	143.46
Day's Range	n/a
52-Week Range	131.76 - 179.60
Beta	1.11
Analysts	Hold
Price Target	157.00 (+10.58%)
Earnings Date	Aug 5, 2025

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 31, 1995
• Employees: 76,000
• Stock Exchange: NYSE
• Ticker Symbol: DVA
• Website: https://www.davita.com

Financial Performance

In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.

Analyst Summary

According to 4 analysts, the average rating for DVA stock is "Hold." The 12-month stock price target is $157.0, which is an increase of 10.58% from the latest price.

Price Target

$157.0

(10.58% upside)

Analyst Consensus: Hold